From Health Canada:
Health Canada has recently completed its review of Merck Frosst’s reports pertaining to a lot (1529U) of measles, mumps and rubella (MMR) vaccine potentially associated with six cases of suspected anaphylaxis in young adults in Alberta during November and December 2007. The review found no link between this vaccine lot and the adverse events in Alberta.
Based on this information, the suspension of this lot (1529U) and two other associated lots (1528U and 1680U) have been lifted and are available for use by provinces and territories to vaccinate both adults and children requiring MMR immunization. Health Canada had asked provincial and territorial health authorities and all other Canadian vaccine providers on December 11, 2007 not to use these lots of the MMR-II vaccine sold by Merck Frosst Canada. At that time, Health Canada requested that Merck Frosst Canada provide a written report on any manufacturing or safety problems associated with Lot 1529U and its bulk components to complement other ongoing investigative efforts. ...more
Showing posts with label mumps vaccine. Show all posts
Showing posts with label mumps vaccine. Show all posts
Wednesday, March 05, 2008
Sunday, December 23, 2007
Calgary resumes routine vaccinations
From the Globe and Mail:
Routine measles, mumps and rubella vaccinations have resumed for children in Calgary, officials said yesterday, ending the suspension to the program ordered this month after a cluster of serious allergic reactions.
The Calgary Health Region, which is battling a mumps outbreak among young adults that has hit Alberta, said yesterday it has found a new supply of the MMR vaccine. ...more
Routine measles, mumps and rubella vaccinations have resumed for children in Calgary, officials said yesterday, ending the suspension to the program ordered this month after a cluster of serious allergic reactions.
The Calgary Health Region, which is battling a mumps outbreak among young adults that has hit Alberta, said yesterday it has found a new supply of the MMR vaccine. ...more
Monday, December 17, 2007
Mumps vaccine being probed for allergy links
From the Globe and Mail:
Health officials across the country are being told to stop using a measles, mumps and rubella vaccine that is now being investigated for possible links to six cases of serious allergic reactions in patients in Alberta.
All six people, who were treated and have fully recovered, received an inoculation from the same batch of a product known as MMR-II, which is sold by Merck Frosst Canada Ltd. They experienced anaphylaxis, a potentially fatal reaction.
But the Quebec-based company said two other lots of the vaccine were made with the same material and are affected by Health Canada's warning to suspend use until a probe is completed. ...more
Health officials across the country are being told to stop using a measles, mumps and rubella vaccine that is now being investigated for possible links to six cases of serious allergic reactions in patients in Alberta.
All six people, who were treated and have fully recovered, received an inoculation from the same batch of a product known as MMR-II, which is sold by Merck Frosst Canada Ltd. They experienced anaphylaxis, a potentially fatal reaction.
But the Quebec-based company said two other lots of the vaccine were made with the same material and are affected by Health Canada's warning to suspend use until a probe is completed. ...more
Subscribe to:
Posts (Atom)